1. Bortin MM (1987) Factors influencing the risk of acute graft-vs-host disease in man. Progress in Bone Marrow Transplantation R P Gale and R Champlin (eds) Alan R Liss, Inc., New York pp 243
2. Deeg HJ, Doney K, Sullivan KM, Witherspoon RP, Appelbaum FR, Storb R (1987) Prevention and treatment of graft-versus-host disease (GVHD) with drugs. Progress in Bone Marrow Transplantation, Alan R Liss, Inc., R P Gale and R Champlin (eds) pp 265
3. Deeg HJ. Storb R (1984) Graft-versus-host disease: pathophysiological and clinical aspects. Ann Rev Med 35: 11
4. Forman SJ, Blume KG, Krance RA, Miner PJ, Metter GE, Hill LR, O’Donnell MR, Nade-manee AP, Snyder DS (1987) A prospective randomized study of acute graft-v-host-disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone. Transplant Proc 19: 2605
5. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18: 295